Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zevra Therapeutics (ZVRA) Operating Income (2016 - 2025)

Historic Operating Income for Zevra Therapeutics (ZVRA) over the last 11 years, with Q3 2025 value amounting to $4.1 million.

  • Zevra Therapeutics' Operating Income rose 11517.25% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$87.7 million, marking a year-over-year decrease of 107.21%. This contributed to the annual value of -$87.0 million for FY2024, which is 7539.51% down from last year.
  • Latest data reveals that Zevra Therapeutics reported Operating Income of $4.1 million as of Q3 2025, which was up 11517.25% from -$71.0 million recorded in Q2 2025.
  • Zevra Therapeutics' Operating Income's 5-year high stood at $7.0 million during Q1 2021, with a 5-year trough of -$71.0 million in Q2 2025.
  • For the 5-year period, Zevra Therapeutics' Operating Income averaged around -$12.8 million, with its median value being -$9.1 million (2022).
  • As far as peak fluctuations go, Zevra Therapeutics' Operating Income surged by 28437.09% in 2021, and later plummeted by 59020.98% in 2023.
  • Quarter analysis of 5 years shows Zevra Therapeutics' Operating Income stood at -$2.8 million in 2021, then crashed by 221.67% to -$9.1 million in 2022, then crashed by 65.8% to -$15.2 million in 2023, then fell by 1.71% to -$15.4 million in 2024, then skyrocketed by 126.87% to $4.1 million in 2025.
  • Its Operating Income was $4.1 million in Q3 2025, compared to -$71.0 million in Q2 2025 and -$5.4 million in Q1 2025.